7z04
From Proteopedia
(Difference between revisions)
(New page: '''Unreleased structure''' The entry 7z04 is ON HOLD Authors: Fruergaard, M.U., Dach, I., Andersen, J.L., Ozol, M., Shasavar, A., Quistgaard, E.M., Poulsen, H., Fedosova, N.U., Nissen, ...) |
|||
(4 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==10 mM Rb+ soak of beryllium fluoride inhibited Na+,K+-ATPase, E2-BeFx (rigid body model)== | |
+ | <StructureSection load='7z04' size='340' side='right'caption='[[7z04]], [[Resolution|resolution]] 7.50Å' scene=''> | ||
+ | == Structural highlights == | ||
+ | <table><tr><td colspan='2'>[[7z04]] is a 6 chain structure with sequence from [https://en.wikipedia.org/wiki/Sus_scrofa Sus scrofa]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7Z04 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7Z04 FirstGlance]. <br> | ||
+ | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 7.5Å</td></tr> | ||
+ | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BEF:BERYLLIUM+TRIFLUORIDE+ION'>BEF</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene></td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7z04 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7z04 OCA], [https://pdbe.org/7z04 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7z04 RCSB], [https://www.ebi.ac.uk/pdbsum/7z04 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7z04 ProSAT]</span></td></tr> | ||
+ | </table> | ||
+ | == Function == | ||
+ | [https://www.uniprot.org/uniprot/AT1B1_PIG AT1B1_PIG] This is the non-catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of Na(+) and K(+) ions across the plasma membrane. The beta subunit regulates, through assembly of alpha/beta heterodimers, the number of sodium pumps transported to the plasma membrane. | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | The Na(+),K(+)-ATPase generates electrochemical gradients of Na(+) and K(+) across the plasma membrane via a functional cycle that includes various phosphoenzyme intermediates. However, the structure and function of these intermediates and how metal fluorides mimick them require further investigation. Here, we describe a 4.0 A resolution crystal structure and functional properties of the pig kidney Na(+),K(+)-ATPase stabilized by the inhibitor beryllium fluoride (denoted E2-BeF(x)). E2-BeF(x) is expected to mimic properties of the E2P phosphoenzyme, yet with unknown characteristics of ion and ligand binding. The structure resembles the E2P form obtained by phosphorylation from inorganic phosphate (P(i)) and stabilized by cardiotonic steroids, including a low-affinity Mg(2+) site near ion binding site II. Our anomalous Fourier analysis of the crystals soaked in Rb(+) (a K(+) congener) followed by a low-resolution rigid-body refinement (6.9-7.5 A) revealed preocclusion transitions leading to activation of the dephosphorylation reaction. We show that the Mg(2+) location indicates a site of initial K(+) recognition and acceptance upon binding to the outward-open E2P state after Na(+) release. Furthermore, using binding and activity studies, we find that the BeF(x)-inhibited enzyme is also able to bind ADP/ATP and Na(+). These results relate the E2-BeF(x) complex to a transient K(+)- and ADP-sensitive E *P intermediate of the functional cycle of the Na(+),K(+)-ATPase, prior to E2P. | ||
- | + | The Na(+),K(+)-ATPase in complex with beryllium fluoride mimics an ATPase phosphorylated state.,Fruergaard MU, Dach I, Andersen JL, Ozol M, Shahsavar A, Quistgaard EM, Poulsen H, Fedosova NU, Nissen P J Biol Chem. 2022 Sep;298(9):102317. doi: 10.1016/j.jbc.2022.102317. Epub 2022 , Aug 2. PMID:35926706<ref>PMID:35926706</ref> | |
- | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
- | [[Category: | + | </div> |
- | [[Category: Andersen | + | <div class="pdbe-citations 7z04" style="background-color:#fffaf0;"></div> |
- | [[Category: | + | == References == |
- | [[Category: | + | <references/> |
- | [[Category: Fruergaard | + | __TOC__ |
- | [[Category: Nissen | + | </StructureSection> |
- | [[Category: | + | [[Category: Large Structures]] |
- | [[Category: | + | [[Category: Sus scrofa]] |
- | [[Category: Quistgaard | + | [[Category: Andersen JL]] |
- | [[Category: | + | [[Category: Dach I]] |
+ | [[Category: Fedosova NU]] | ||
+ | [[Category: Fruergaard MU]] | ||
+ | [[Category: Nissen P]] | ||
+ | [[Category: Ozol M]] | ||
+ | [[Category: Poulsen H]] | ||
+ | [[Category: Quistgaard EM]] | ||
+ | [[Category: Shasavar A]] |
Current revision
10 mM Rb+ soak of beryllium fluoride inhibited Na+,K+-ATPase, E2-BeFx (rigid body model)
|
Categories: Large Structures | Sus scrofa | Andersen JL | Dach I | Fedosova NU | Fruergaard MU | Nissen P | Ozol M | Poulsen H | Quistgaard EM | Shasavar A